StockWatch
·
CAPACITE INFRAPROJECTS LTD · QQ1 FY-2027 · THE CALL

Guidance reaffirmed but Q1 delivery soft; H2 execution critical

The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.

Q1 FY27 resultsCAPACITECapacite Infraprojects Ltd17 Aug 2026 · 6 min read
Verdict

Hold

confidence 6/10

Credibility

Grade C

Guided 20% revenue growth YoY; Q1 delivered 6.7%. Reaffirmed guidance despite miss, citing external factors only.

Short-term outlook

Cautiously Optimistic

next 1–2 quarters

Long-term outlook

Optimistic

multi-year

Strong order backlog (₹13.5K Cr) and bid pipeline (₹27K Cr) support multi-year growth, but Q1 revenue (+6.7%) and PAT (-15.2%) sharply miss the 20% guidance. Execution risk is high: major projects (IIT, NBCC, CIDCO) are behind schedule, margin is compressed by commodity inflation, and management's claim to catch up in H2 remains unproven. Hold until execution tangibly improves.

₹628.9 Cr

Revenue · +6.7% YoY

₹39.8 Cr

Reported PAT · −15.2% YoY

Compressing

Margins · vs guidance: Overstated

Did the claims hold up?

Management's claims vs. the numbers

20% revenue growth guidance well on track for full year

OVERSTATED

Q1 delivered only 6.7% YoY growth; needs ~28% avg H2 to hit 20% full year

Workmen shortages resolved, confident of full-year guided performance

Partial

Labor normalized in June but Q1 already delivered; benefit unproven in Q2 yet

EBITDA margin 15.5–16.5% for FY27 is achievable

MET

Q1 at 15.7% within range but down from 17.2% YoY; compressed by ₹10 Cr provision

Strong order book of ₹13,535 Cr to drive revenue acceleration

MISS

Order book solid but execution constrained; IIT Bombay delayed, NBCC late to ramp, CIDCO only 2 of 7 locations active

Earnings quality

What changed since the last call

Deltas vs. the prior call

CapEx guidance raised

Upgrade

₹165 Cr → ₹193 Cr (+₹28 Cr). Split: ₹121 Cr aluminum formwork, ₹56 Cr plant/machinery. Reflects new project needs and high-rise buildlings.

Revenue growth stalled

Downgrade

Prior 22% FY25, 12% FY26; Q1 FY27 is 6.7%. No formal guidance cut but implied path to 20% FY much harder post Q1 softness.

Commodity provision doubled

Downgrade

₹10 Cr Q4 FY26 + ₹10 Cr Q1 FY27 = ₹20 Cr total hedges. Aluminum +35–40%, copper exposed; indices lag actual costs.

Order book size stable but execution timeline slipped

Neutral

₹13.5K Cr OB unchanged but major projects (IIT, CIDCO, NBCC) all started later than prior-call plan. No order quantity cut, only timeline slip.

Debt reduction plan maintained

Neutral

Gross debt ₹522 Cr (up from Q4 due to payment timing, not structural increase). Net debt-free in 8 quarters reaffirmed despite CapEx uplift.

The Q&A

Analysts pressed hard on execution bottleneck: revenue growth slowed 22% → 12% → 6.7%, yet order book is 5x revenue. Management defended citing project-specific delays (tree permits, labor, client handover sequencing), reaffirmed 20% target, and argued bulk of revenue will come Q2–Q4. No admission of internal constraints; blamed only externals. Credibility questioned but not broken.

The exchanges that mattered

Revenue execution vs order book — Vinay Chaudhary, Invexa Capital

Partial

IIT Bombay delayed by tree-cut permissions (should have ₹65–70 Cr Q1 revenue), NBCC only started ramping now (threefold increase coming), CIDCO only 2 of 7 locations handed over. Projects will ramp Q2–Q3. CAGR 2022–26 is ~20%, PAT CAGR >40%, so conversion track record is sound.

Commodity provisions reversal — Vinay Chaudhary, Invexa Capital

Answered

Aluminum up 35–40%, price variation not reflected yet in CPWD indices. Substantial portion expected to reverse Q3–Q4 as indices catch up. We've historically reversed large provisions over 7–8 years. Wait-and-watch approach; indices govern, not company opinion.

Revenue slowdown root cause — Vedant Kabra, Nuvama

Partial

Not a bottleneck issue. CIDCO ₹2.5K Cr yet to start, NBCC rising from ₹15 Cr/month to ₹60 Cr/month, IIT Bombay just started. Order book includes sites not yet active. Our CAGR is 18% consol; 20% FY27 guidance means slight acceleration. Labor and technology improvements will support it from Q3–Q4.

Contract assets aging and quality — Gunit Singh, Cyclical PMS

Partial

All are milestone-based, cyclical, nothing >1–2 years overdue. CIDCO ₹300 Cr unbilled (work done, milestone pending), MHADA ₹200 Cr unbilled. Contract assets+debtors ratio is 78% (down from 120% post-COVID). Targeting leadership position by March 2028, matching pre-COVID levels.

Gross debt and capex impact — Vaibhav Shah, JM Financial

Answered

Gross debt up due to ₹150 Cr payment timing shift (already collected in current month), not structural. Equipment purchase may increase debt ₹45–50 Cr net. Working capital improving 25–30 days this year (like last year's 40 days reduction). Net debt trajectory on track.

Order backlog value and pricing — Vaibhav Shah, JM Financial

Partial

Not '7 buildings' — total balance area is ₹2,000 Cr + escalation (28% price variation currently). In OB, we've booked ₹2,000 Cr. As locations handed over, we'll clarify building-by-building breakdown in Q2 call. Price variation can swing ±2–5%.

Provisioning and margin outlook — Deepak Poddar, Sapphire Capital

Answered

No provisioning expected Q2; will wait for Q3 indices before Q3 call commentary. EBITDA margins exclude other income. If prices stabilize and indices catch up, reversals in Q3–Q4.

Working capital and net debt-free timeline — Rahul Kumar, Vaikarya Fund

Answered

Net working capital has improved 43 days last year. Expect 25–30 days improvement this year. Contract assets+receivables declining. Ideally revert to pre-COVID 56–72 days. March 2027 to March 2028 we should hit leadership position.

Guidance

Forward guidance and management's confidence

FY27 revenue growth 20% YoY

Medium

Reaffirmed explicitly despite Q1 at +6.7%. Needs H2 to average ~28% growth. Executive team confident, citing Q2 Labor improved, IIT/NBCC/CIDCO/MHADA ramp Q2–Q4.

EBITDA margin FY27: 15.5–16.5%

Medium

Q1 at 15.7% within range but lower half. Commodity provisions headwind; reversal hope Q3–Q4 if escalation indices catch up. Risk of further provisioning if indices lag.

CapEx FY27: ₹193 Cr (raised from ₹165 Cr)

High

Split: ₹121 Cr formwork/aluminum extrusion, ₹56 Cr plant/machinery (high-rise & composite buildings), ₹5.4 Cr IT/SAP. Q1 done ₹52.2 Cr; on track.

Risks the call surfaced

Ranked by how much they should concern a holder

Execution risk (projects delayed)

High

IIT Bombay (₹550 Cr) started Q2 instead of Q4 FY26 due to tree permits. NBCC late to profit ramp. CIDCO only 2 of 7 locations active. These delays cascade into H2 revenue miss.

Commodity inflation and margin pressure

High

Aluminum +35–40%, copper exposed. Government contracts (55–60% of biz) have price variation clauses but indices lag actual purchase costs. ₹10 Cr provision Q4 + ₹10 Cr Q1 = ₹20 Cr total hedges. If indices don't catch up, further provisions or margin cuts needed.

Revenue growth credibility

High

Q1 delivered 6.7% growth YoY; guidance is 20% for full year. To hit 20%, H2 must average ~28% growth. No single quarter since FY25 has delivered >12% growth. Feasibility highly dependent on timing of CIDCO, MHADA, NBCC ramps.

Contract asset aging and realization risk

Medium

Contract assets + debtors at 78% of revenue (down from 120% post-COVID). Nothing is >1–2 years overdue (all milestone-based), but high absolute amount suggests working capital intensity. Any client payment delays cascade into cash burn.

External constraints (permits, labor, environment)

Medium

Q1 hit by Mumbai water cuts, labor shortages (30% in June), tree permits (IIT). Delhi NCR GRAP (Nov–Jan) could cost ~20 days or more if AQI >400. Management factored these in but external risk remains high.

Management

Score 6/10. Detailed on project-level breakdowns (CIDCO, MHADA, NBCC, IIT, Signature Global); transparent on order pipeline (₹27K Cr identified bids). However, defensive on guidance miss (blames only externals, no internal accountability). Some questions (contract asset aging) deflected to offline conversation. Track record mixed: FY26 guided 20%, delivered 12%. CAGR 2022–26 solid at ~18–20% consol, but recent slowdown (22% FY25 → 12% FY26 → 6.7% Q1 FY27) is concerning. PAT CAGR >40% prior years now down -15.2% YoY, showing profitability weakness.

What to watch next
  • 1 · Q2 FY27 (Sept 2026)

    IIT Bombay execution ramp, NBCC monthly run rate to ₹60 Cr, CIDCO land handover begins

  • 2 · Q3 FY27 (Dec 2026)

    Major revenue inflection from 4+ new project locations; CIDCO ₹75+ Cr, MHADA ₹75 Cr, others

  • 3 · Delhi NCR GRAP (Nov–Jan)

    Construction ban for ~20 days; management factored this, but risk if AQI > 400

Hold until execution tangibly improves.

Informational and educational content only. Not investment advice.